On July 4th, 2003, CEO Ryu Ogawa gave a presentation at the 23rd Annual Meeting of the Protein Science Society of Japan. During his talk, he hilighted our latest advancements in AI-driven antibody design, through collaboration with US pharmaceutical companies.

Link: https://www.pssj.jp/news/2023/04/25/protein-engineering-202307.html